NCT06940284

Brief Summary

The objectives of the present study are: 1) to characterize the energy-protein intake of the elderly during hospitalization; 2) to verify the influence of energy-protein intake during hospitalization on muscular (i.e., cross-sectional area of the rectus femoris and vastus lateralis muscles, muscle strength, functionality and level of independence) and clinical (i.e., length of hospital stay, hospital readmission and mortality) at the time of hospital discharge, 2 and 6 months after hospital discharge and; 3) to verify whether energy-protein intake during hospitalization is a significant predictor of loss of function and muscle mass, length of hospital stay, hospital readmission rate and mortality.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 14, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 23, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

May 1, 2025

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 30, 2026

Completed
Last Updated

May 23, 2025

Status Verified

May 1, 2025

Enrollment Period

9 months

First QC Date

April 14, 2025

Last Update Submit

May 22, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Vastus Lateralis Muscle Cross-sectional Area

    Vastus Lateralis Muscle Cross-sectional Area will be assessed through ultrasound

    From date of admission until the date of medical discharge. Up to 30 days.

Secondary Outcomes (6)

  • Handgrip strength

    From date of admission until the date of medical discharge. Up to 30 days.

  • Muscle function

    From date of admission until the date of medical discharge. Up to 30 days.

  • Functional independence

    From date of admission until the date of medical discharge. Up to 30 days.

  • Length of hospital stay

    From date of admission until the date of medical discharge. Up to 30 days.

  • Mortality

    From date of admission until the date of medical discharge. Up to 30 days.

  • +1 more secondary outcomes

Study Arms (1)

Older individuals hospitalized

Older adults admitted to the hospital within the past 48 hours, without signs of delirium, and able to receive oral nutrition and complete muscle function assessments.

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Older individuals hospitalized

You may qualify if:

  • both sex;
  • years and older;
  • hospital stay less than 48 hours;

You may not qualify if:

  • cancer in the last 5 years;
  • delirium;
  • cognitive deficit that impossibility the patient to read and sign the informed consent form;
  • neurological disease;
  • neurodegenerative muscular disease;
  • patients receive nutrition via enteral and parenteral routes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Sao Paulo

São Paulo, São Paulo, 05508-030, Brazil

RECRUITING

MeSH Terms

Conditions

Muscular AtrophyMalnutrition

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and SymptomsNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Hamilton Roschel, PhD

    University of Sao Paulo General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Hamilton Roschel, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

April 14, 2025

First Posted

April 23, 2025

Study Start

May 1, 2025

Primary Completion

January 30, 2026

Study Completion

January 30, 2026

Last Updated

May 23, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations